Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Practical Application of Behavioral Coaching Techniques
This case study showcases the power of behavioral coaching techniques in transforming an injured employee’s recovery. Through empathy, active listening, and strategic intervention, Enlyte’s Telephonic Case Manager helped break barriers to healing—leading to improved outcomes, renewed engagement and meaningful cost savings.
From Setback to Comeback: Effective Solutions for Delayed Recovery
Learn how to effectively ignite workers' compensation recovery by addressing some of the biggest return-to-work obstacles, including mental health comorbidities, social factors, and delayed intervention. See how data-driven strategies lead to successful claims management and faster employee recovery.
Pulsing Recovery: Bone Growth Stimulation's Impact on Comp
Discover how bone growth stimulators are accelerating recovery in workers’ comp. Nicole Usher joins the Enlyte Envision podcast to discuss how BGS devices support healing in complex fractures and spinal surgeries.
Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.
The AI Balancing Act: Navigating Innovation in Workers’ Compensation
Industry expert Michael Cwynar of Enlyte discusses how to strike the right balance between AI innovation and professional expertise in today’s rapidly evolving tech landscape.
10 Ways Field Case Management Can Make a Difference
Enlyte's field case management provides empathetic, innovative support for injured employees, guiding recovery with tailored solutions. Discover how our comprehensive approach can enhance your workers' compensation outcomes.